Pricing pressures and access to medicine – rethinking commercial strategies & drug development costs to improve affordability in lower-income markets
Introduction Access to medicines in low-income markets remains a significant challenge, exacerbated by pricing pressures and high drug development costs. Populations in these regions often face limited access to essential treatments, worsening health inequalities. As pharmaceutical companies strive to balance profitability with social responsibility, it becomes imperative to rethink commercial strategies and reduce drug development […]
